Cartesian Therapeutics (RNAC) Other Working Capital Changes (2016 - 2025)
Historic Other Working Capital Changes for Cartesian Therapeutics (RNAC) over the last 11 years, with Q3 2025 value amounting to $438000.0.
- Cartesian Therapeutics' Other Working Capital Changes changed N/A to $438000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 16848.91%. This contributed to the annual value of -$5.8 million for FY2024, which is 21128.23% down from last year.
- Cartesian Therapeutics' Other Working Capital Changes amounted to $438000.0 in Q3 2025.
- Cartesian Therapeutics' Other Working Capital Changes' 5-year high stood at $9.2 million during Q1 2023, with a 5-year trough of -$26.9 million in Q1 2022.
- For the 5-year period, Cartesian Therapeutics' Other Working Capital Changes averaged around -$6.2 million, with its median value being -$2.7 million (2021).
- As far as peak fluctuations go, Cartesian Therapeutics' Other Working Capital Changes plummeted by 457213.11% in 2021, and later skyrocketed by 20722.83% in 2025.
- Cartesian Therapeutics' Other Working Capital Changes (Quarter) stood at -$17.1 million in 2021, then soared by 49.26% to -$8.7 million in 2022, then soared by 73.77% to -$2.3 million in 2023, then soared by 81.87% to -$412000.0 in 2024, then skyrocketed by 206.31% to $438000.0 in 2025.
- Its Other Working Capital Changes stands at $438000.0 for Q3 2025, versus -$706000.0 for Q2 2025 and $5.8 million for Q1 2025.